Paratek Pharmaceuticals, Inc. Quarterly Cost of Revenue in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Paratek Pharmaceuticals, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2019 to Q2 2023.
  • Paratek Pharmaceuticals, Inc. Cost of Revenue for the quarter ending June 30, 2023 was $4.37M, a 10.5% decline year-over-year.
  • Paratek Pharmaceuticals, Inc. Cost of Revenue for the twelve months ending June 30, 2023 was $25.3M, a 45.6% increase year-over-year.
  • Paratek Pharmaceuticals, Inc. annual Cost of Revenue for 2022 was $23.1M, a 7.06% increase from 2021.
  • Paratek Pharmaceuticals, Inc. annual Cost of Revenue for 2021 was $21.5M, a 149% increase from 2020.
  • Paratek Pharmaceuticals, Inc. annual Cost of Revenue for 2020 was $8.65M, a 148% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $25.3M $4.37M -$510K -10.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $25.8M $6.24M +$2.75M +78.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $23.1M $10.3M +$5.6M +119% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 $17.5M $4.37M +$83K +1.94% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $17.4M $4.88M -$4.9M -50.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $22.3M $3.49M +$743K +27% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $21.5M $4.72M +$1.79M +61.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $19.7M $4.29M +$2.27M +113% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $17.5M $9.78M +$7.54M +337% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $9.93M $2.75M +$1.28M +87% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $8.65M $2.93M +$1.17M +67% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $7.48M $2.02M +$1.06M +111% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $6.42M $2.24M +$1.67M +294% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $4.75M $1.47M +$1.27M +614% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $3.48M $1.75M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-29
Q3 2019 $958K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $567K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $206K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.